Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Peter_DeYoung
|
| gptkbp:country |
gptkb:India
|
| gptkbp:foundedBy |
gptkb:Ajay_Piramal
|
| gptkbp:headquartersLocation |
gptkb:Mumbai
|
| https://www.w3.org/2000/01/rdf-schema#label |
Piramal Pharma
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:listedSince |
2022
|
| gptkbp:market |
global
|
| gptkbp:numberOfEmployees |
over 6000
|
| gptkbp:parentCompany |
gptkb:Piramal_Group
|
| gptkbp:products |
over-the-counter products
active pharmaceutical ingredients pharmaceutical formulations |
| gptkbp:stockExchange |
gptkb:NSE
BSE |
| gptkbp:stockSymbol |
PPLPHARMA
|
| gptkbp:subsidiary |
Piramal Consumer Products Division
Piramal Critical Care Piramal Pharma Solutions |
| gptkbp:website |
https://www.piramalpharma.com/
|
| gptkbp:bfsParent |
gptkb:Piramal_Enterprises
|
| gptkbp:bfsLayer |
6
|